OI and IUI Flashcards
WHO Classification of Ovulatory Disorders
I: Hypo-hypo (5-10%)
II: Normo-normo (75-85%)
III: Hyper-hypo (10-20%)
IV: Hyper PRL (5-10%)
Reqts
evidence of ovulation in the IUI cycle
at least 1 patent tube
>5-10M sperm motile (CPG)
no active infection
moa clomiphene
a selective estrogen receptor modulator that
binds to estrogen receptors for an extended period of time, this messes with receptor recycling and causes a feedback to your hypothalamus to stimulate GnRH and gonadotropin production because there is a perceived low level of estrogen –> this drives follicular development
in ovulatory women: inc pulse frequency
in anovulatory women: inc pulse amplitude
side effects clomiphene
dec cervical mucus quality
dec endometrial growth
% fecundability
expectant v cc v gonadotropins v ivf
2-4%
5-10%
7-10%
25-45%
T or F:
in anovulatory women, OI + IUI is not superior to OI + timed coitus if normal semen parameters
T
T or F:
in ovulatory women, OI + IUI is not superior to OI + timed coitus if normal semen parameters
F
add IUI to inc number of sperm
cycle fecundability for OI with CC in ANOVULATORY women
15-22%
side effects CC
hot flashes
VMS
headache
breast tenderness
pelvic pressure
n/v
visual disturbances (scotomata, light sensitivity, double vision)
afterimages (palinopsia)
photophobia
risks of CC
multiple pregnancy (7-10%)
no causal relationshop:
breast CA (high doses and multiple cycles)
endomCA (baka kasi yung anovulatory nature nung patient yung cause)
adjuvant
Glucocorticoids on D5-14
Prednison 5mg OD x 10 days
or
Dexa 0.5-2.0 mg OD x 10 days
Metformin
HCG trigger
(CC)
if not properly timed administration, results to atresia
given if lead follicle is 20 mm in diameter
ovulation 34-36hours after, IUI done at 36th hour
(as opposed to using LH kit, which detects the surge so 14-26 hours is ovulation –> next day ka mag IUI… usually 4-6pm ka nagtetest diba)
gonadotropins indications
- hypo-hypo (must contain both FSH and LH)
2.oral OI agents resistant (theoretically beneficial if FSH only so u dont augment LH)
- unexplained infertility
letrozole MOA
competitive nonsteroidal inhibitor of aromatase
block estrogen production in the periphery and brain –> stimulate gonadotropin secretion to stimulate follicular development
results to lower E2 and higher P4 during luteral phase = higher LBR
inc ovulation, PR, CPR for clomiphene resistant
no adverse endometrial effect
side effects letrozole
fatigue
dizziness